The Valens Company (TSE:VLNS) (OTCQX:VLNCF) (FRA:7LV) announced the launch of its nuance branded CBD 100 product, a high-potency CBD-dominant oil that will be available in the Medical Cannabis by Shoppers marketplace in the coming weeks.
The company noted that it previously launched several other nūance products for Medical Cannabis by Shoppers' patients, including oils and vapes in various blends and potencies, and expects to unveil additional products in the coming quarters such as topical formats like bath bombs, body oil, moisturizer, and relief rub, as well as water drops and additional premium oils.
Valens added that CBD 100 will join nūance's line-up of premium cannabis health and wellness products developed with trusted ingredients and approachable formulations that enable both simplified and customized consumer dosing.
READ: Valens scales up and begins to show what it was 'made to do'
In creating the product, the company said it has utilized its proprietary extraction technology to isolate high purity cannabidiol (CBD) while carefully curating the naturally-sourced nūance CBD 100 formulation to deliver a light and natural taste by blending MCT oil and flavourless CBD crystalline and ensuring THC is below detectable levels.
The product is packaged in a 30ml bottle with a drip-controlled dispensing mechanism designed to allow consumers to personalize their dosage and incorporate the product into their wellness routine.
It added that two drops of the oil are equal to about 5mg of CBD, and potency of the product may vary batch by batch.
The Valens Company is a profitable British Columbia-based producer of cannabis products, medical and recreational, and it is scaling up operations.
The firm can process over 425,000 kilograms of biomass per year and its services include numerous types of proprietary extraction, analytical testing, formulation, cultivation, and research, as well as white label product development.
Its products include tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, edibles, injectables, and natural health products and it has a strong pipeline of next-generation products in development.
Contact Sean at sean@proactiveinvestors.com